These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bioanalytical method validation: notable points in the 2009 draft EMA Guideline and differences with the 2001 FDA Guidance. Smith G Bioanalysis; 2010 May; 2(5):929-35. PubMed ID: 21083222 [No Abstract] [Full Text] [Related]
3. Cancer-causing substances in food, drugs, and cosmetics. The de minimis rule versus the Delaney clause. Curran WJ N Engl J Med; 1988 Nov; 319(19):1262-4. PubMed ID: 3273488 [No Abstract] [Full Text] [Related]
4. Science and health regulation. Kennedy D J Dent Educ; 1980 Aug; 44(8):473-7. PubMed ID: 6930415 [No Abstract] [Full Text] [Related]
5. Role of AOAC in the regulation of food safety. Butler SJ J Assoc Off Anal Chem; 1979 Mar; 62(2):226-8. PubMed ID: 447593 [No Abstract] [Full Text] [Related]
6. FDA reissues proposal for evaluating assays for carcinogenic compounds. Vet Hum Toxicol; 1979 Jun; 21(3):208-9. PubMed ID: 462744 [No Abstract] [Full Text] [Related]
8. A visit from the FDA. Brett J J Am Vet Med Assoc; 1994 May; 204(9):1319-20. PubMed ID: 8050959 [No Abstract] [Full Text] [Related]
9. Winchester: facility with versatility. Hecht A FDA Consum; 1975 Nov; 9(9):4-9. PubMed ID: 10308124 [No Abstract] [Full Text] [Related]
10. Criteria for extra-label drug use debated at FDA Advisory Committee meeting. Raef TA J Am Vet Med Assoc; 1995 Jul; 207(1):10-1. PubMed ID: 7601683 [No Abstract] [Full Text] [Related]
11. FDA backs legislation to restrict antimicrobial use. Cima G J Am Vet Med Assoc; 2009 Sep; 235(5):493-5. PubMed ID: 19731457 [No Abstract] [Full Text] [Related]
12. The FDA takes action against unapproved drugs. Meadows M FDA Consum; 2007; 41(1):34-5. PubMed ID: 17342837 [TBL] [Abstract][Full Text] [Related]
13. Editorial: Is the FDA too fearsome? Berry FB Med Times; 1973 Oct; 101(10):15 passim. PubMed ID: 4755498 [No Abstract] [Full Text] [Related]
14. Sundlof outlines vision for FDA to council. J Am Vet Med Assoc; 1995 Feb; 206(3):275-6. PubMed ID: 7751227 [No Abstract] [Full Text] [Related]
15. FDA policy and regulation of stereoisomers: paradigm shift and the future of safer, more effective drugs. Strong M Food Drug Law J; 1999; 54(3):463-87. PubMed ID: 11797710 [No Abstract] [Full Text] [Related]
16. Perspectives. Hitting the FDA ... again. Wiener JO Faulkner Grays Med Health; 1990 Oct; 44(41):suppl 4 p.. PubMed ID: 10107287 [No Abstract] [Full Text] [Related]
18. FDA extra-label use policy: 1992 revisions. Guest GB; Solomon SM J Am Vet Med Assoc; 1993 May; 202(10):1620-3;discussion 1626-31. PubMed ID: 8514568 [No Abstract] [Full Text] [Related]
19. Bioavailability and bioequivalence requirements: abbreviated applications. Final Rule. Food and Drug Administration, HHS Fed Regist; 2002 Dec; 67(244):77668-75. PubMed ID: 12492102 [TBL] [Abstract][Full Text] [Related]
20. Current FDA policy on use of human-labeled drugs in animals. Teske RH J Am Vet Med Assoc; 1993 May; 202(10):1632-3;discussion 1634. PubMed ID: 8514570 [No Abstract] [Full Text] [Related] [Next] [New Search]